The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from liver failure after taking it or a similar treatment.
Related Posts
Biden Awards $150 Million in Research Grants as Part of Cancer ‘Moonshot’
President Biden has had a deep personal interest in cancer research since his son Beau died of an aggressive brain…
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
In June 2021, the insurance plan for North Carolina state employees was paying for 2,800 people to take weight-loss drugs.…
FDA Nominee Marty Makary to Face Grilling Over Cutbacks and Policy Shifts
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and…